《Drug Resistance in Cancer Therapy》是一本圖書,作者是Ozols, Robert F.
基本介紹
- ISBN:9780792302445
- 作者:Ozols, Robert F.
- 出版時間:1989年8月
- 頁數:224
- 定價:$ 337.87

《Drug Resistance in Cancer Therapy》是一本圖書,作者是Ozols, Robert F.
《Drug Resistance in the Treatment of Cancer》是一本圖書,作者是Pinedo, Herbert M.; Giaccone, Giuseppe; Herbert M., Pinedo 內容簡介 The development of drug-resistant cancers is considered to be the most significant obstacle to the cure of cancer today. Nearly half of all patients with cance...
《Recent Advances in Cancer Research and Therapy(癌症研究及其治療的最新進展)》是2013年清華大學出版社出版的圖書,作者是劉新垣、(美)帕斯卡、時玉舫。內容簡介 《癌症研究及其治療的最新進展》集全球癌症研究與治療領域的高水平專家集體之力,全面介紹了目前癌症領域的最新研究...
The third edition of Gene Therapy of Cancer provides crucial updates on the basic and applied sciences of gene therapy. It offers a comprehensive assessment of the field, including the areas of suicide gene therapy, oncogene and suppressor gene targeting, immunotherapy, drug resistance gene therapy,...
Radioiodine therapy in advanced differentiated thyroid cancer: Resistance and overcoming strategy,Drug Resist Updat. 2023 May The tumor ecosystem in head and neck squamous cell carcinoma and advances in ecotherapy,Mol Cancer. 2023 Apr 6 Research progress on non-protein-targeted drugs for cancer ...
(23) Zou Zhengzhi, Zhang Qiongxia, Long Zijie, Chen, Yuan Zhongyu Jinna Tang, Zhiping Zhu Yuliang, Chen Shupeng, Xu Jie, Yan Min, Wang Jing, Liu Quentin(*), Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells.,Autophagy,2012,8(12):1798-1810.(24...
Now the most viewpoints are that hepatoma is a chemical therapy drug resistance disease, one of the important causes of failed therapy and relapsed cancer is the hepatocyte's drug resisitence.目前多數觀點認為肝癌屬於化療耐藥性疾病,肝癌細胞產生耐藥性是化療失敗及肝癌復發的主要原因之一。
截止2024年11月,徐瑞華以通訊或第一作者在國際期刊《新英格蘭醫學雜誌》(NEJM)、JAMA(2篇)、BMJ、Cell、Nature Med(5篇)、Nature Mater、Lancet Oncol(2篇)、Cancer Cell(3篇)、Ann Oncol(2篇)、JCO(2篇)、Lancet G&H(2篇)、JAMA Oncol(2篇) 等發表高水平成果論文200 余篇(30篇IF>30),...
27. Chen BA*, Wu WW, WangXM. Magnetic Iron Oxide Nanoparticles for Tumor-targeted Therapy. Curr CancerDrug Targets 2011; 11(2):184-9.28. Zhang HJ, Jiang H, Sun FF, Wang HP, Zhao J, Chen BA*, Wang XM. Rapid diagnosis of multidrug resistance in cancerby electrochemical sensor based ...
4. Xie Y, Feng SL, He F, Yan PY, Yao XJ, Fan XX, Leung EL*, Zhou H*. Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer. Pharmacological Research. 2022; 186: 106514. (IF=9.3)5. Wang J, ...
13. Zhang, W., Shen, J., Su, H., Mu, G., Sun, J. H.,Tan, C. P., Liang, X. J., Ji, L. N., Mao, Z. W.* Co-delivery of cisplatin prodrug and chlorin e6 by mesoporous silica nanoparticles for chemo-photodynamic combination therapy to combat drug resistance.ACS Applied ...
5. Chunlai Feng#, Mengjie Rui#, Haijun Shen, Yuanrong Xin, Jie Zhang, Jun Li, Lixiang Yue, Wenlong Lai, Ximing Xu*.Tumor-specific delivery of doxorubicin through conjugation of pH-responsive peptide for overcoming drug resistance in cancer, International Journal of Pharmaceutics, 2017 6. ...
(7) Synergistic effects of A-B-C type amphiphilic copolymer on reversal of drug resistance in MCF-7/ADR breast carcinoma, Lu Zhang, Jiafei Lu, Liyan Qiu*, International Journal of Nanomedicine, 2016, 11, 5205-5220 (8) Polyphosphazene vesicles for co-delivery of doxorubicin and chloroqu...
Yu Chen,Hangrong Chen and Jianlin Shi, Inorganic Nanoparticles-Based Drug Co-Delivery Nanosystems to Overcome the Multidrug Resistance of Cancer Cells,Molecular Pharmaceutics, 2014, 11, 2495-2510.2013年 Yu Chen, Hangrong Chen and Jianlin Shi, In Vivo Bio-Safety Evaluations and Diagnostic/Therapeutic...
Du, R., Liu, B., Zhou, L., Wang, D., He, X., Xu,X., Zhang, L., Niu, C.*, Liu, S.*. Downregulationof annexin A3 inhibits tumor metastasis and decreases drug resistance in breastcancer. Cell Death and Disease 9(2):126,2018. PMID: 29374148 Wang, D., Xu, J., Liu, B....
The Complex Role of Neutrophils in Tumor Angiogenesis and Metastasis. Cancer Immunol Res. 2016 Feb; 4(2):83-91. Liang W, Ferrara N. PMID: 26839309.Ten years of anti-vascular endothelial growth factor therapy. Nat Rev Drug Discov. 2016 06; 15(6):385-403. Ferrara N, Adamis AP. PMID: ...
現是包括Cancer research,Drug Resistance Updates,Cancer letters,Acta Pharmaceutica Sinica B,Journal of Advanced Research,Journal of Experimental & Clinical Cancer Research在內的40家SCI收錄雜誌的特邀審稿人。Molecular and Cellular Biochemistry(二區), Biochemical Pharmaocology(二區,TOP)編委,《中國...
2. (with Haigang Li and Yanyan Li) Gradient estimates for solutions of the Lame system with partially infinite coefficients in dimensions greater than two, Adv. Math. 305 (2017), 298–338.3. (with Xiaoqiang Sun and Yongzhao Shao) Mathematical Modeling of Therapy-induced Cancer Drug Resistanc...
32.Shi Z, Tiwari AK, Shukla S, Robey RW, Singh S, Kim IW, Bates SE, Peng XX, Abraham I, Ambudkar SV, Talele TT, Fu LW*, Chen ZS*. Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug resistance.Cancer Res.2011 Apr 15;71(8):3029-41.(SCI IF: 8.650)33.Shi ...
2024年8月27日,上海大學醫學院卞月珉教授與美國哈佛大學醫學院Jonathan Abraham教授團隊合作,作為共同第一作者,在國際頂級期刊《Cell》(《細胞》)上發表題為《Viral DNA polymerase structures reveal mechanisms of antiviral drug resistance》的研究論文。2024年9月,上海交通大學醫學院腫瘤系統醫學全國重點實驗室沈...
[8] Zhao, Chengguang; Li, Huameng; Lin, Huey-Jen; Yang, Shulin*; Lin, Jiayuh; Liang, Guang.Feedback Activation of STAT3 as a Cancer Drug-Resistance Mechanism. Trends in Pharmacological Sciences, 2016, 37(1): 47-61. [9] Peng Zou, Yiqun Xia, Weiqian Chen, Xi Chen, Shilong Ying, ...
3. Zhen Qu, Junhua Wu#,Junyi Wu, Dongjun Luo, Chunping Jiang* and Yitao Ding*. Exosomes derived fromHCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivoand in vitro. Journal of Experimental & Clinical Cancer Research (2016) 35:159. Co-first author IF: 5.18...
Curcumin potentiates the pro-apoptotic effects of sulindac sulfone in colorectal cancer Giladi N , Kazanov D, Shpitz B, Aroch I, Kraus S and Arber N. Expert Opin Investig Drugs. Apr 2010;19 Suppl 1: S117-124...[10-4-30]Pharmacogenetics in breast cancer: focus on hormone therapy, ...
[38] Liu, L; Yan, L; Liao, N; Wu, WQ; Shi, JL*. A Review of ULK1-Mediated Autophagy in Drug Resistance of Cancer. CANCERS, 2020, 12(2): 352 [39] Zhao, PP; Xu, XG# ; Zhao, XX; Ai, CY; Xu, KY; Li, MX; Jiang, CM; Shi, JL*. Capability of Bacillus Subtilis to ...
11. Yan B. Impacts of Nanotechnology on Medicinal Chemistry and Drug Discovery. Current Medicinal Chemistry 2011, 18(14), 2044.12. Jiao P, Zhou H, Chen L, Yan B.* Cancer-Targeting Multifunctionalized Gold Nanoparticles in Imaging and Therapy. Current Medicinal Chemistry2011, 18(14), 2086-...
155 Renal Replacement Therapy in the Intensive Care Unit William Silvester,MD·Glenn Chertow,MD Claudio Ronco,MD Rinaldo Bellomo,MB BS(HONS),MD,FRACP 156 Drug-Kidney Interactions George J.Kaloyanides,MD,FACP 157 Acute Renal Failure in Infants and Children Claudio Ronco,MD·Massimo Ronconi, MD ...
. Cancer Discovery 期刊IF(2022)=38.27 Pan R (唯一一作), Vivian R, Wei J, Konopleva M, …Andreeff M*. Inhibition of MCL-1 with the pan-BCL-2 family inhibitor (-)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia . Blood 期刊IF(2022)=25.48 Pan R (唯一一作), Wang ...
Shi Z, Li C-y, Zhao S, Yu Y, An N, Liu Y-x, Wu C-f, Yue B-s, Bao J-k*: A systems biology analysis of autophagy in cancer therapy. Cancer Letters 2013, 337(2):149-160.Lin Y, Wang F, Yang L-j, Chun Z, Bao J-k*, Zhang G-l: Anti-inflammatory phenanthrene ...
